Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer
The purpose of this study is to determine the safety and efficacy of this regimen in women with ovarian or peritoneal cancer
Ovarian Carcinoma|Primary Peritoneal Carcinoma
DRUG: Carboplatin|DRUG: Docetaxel
Safety and Efficacy
QOL
The purpose of this study is to determine the safety and efficacy of this regimen in women with ovarian or peritoneal cancer